JPMorgan Chase & Co. Has Lowered Expectations for Amrize (NYSE:AMRZ) Stock Price

Amrize logo with Materials background
Image from MarketBeat Media, LLC.

Key Points

  • JPMorgan cut its Amrize price target from $48 to $46 while maintaining a neutral rating; the new target implies 14.45% upside from the price cited in the report.
  • Analyst views are mixed: MarketBeat reports a consensus “Hold” rating and an average price target of $47.07, with eight Buy, seven Hold, and five Sell recommendations.
  • Amrize reported quarterly earnings of $1.05 per share, matching estimates, while revenue rose 2.6% year over year to $3.77 billion. Company insiders also bought shares over the past three months.
  • MarketBeat previews the top five stocks to own by December 1st.

Amrize (NYSE:AMRZ - Get Free Report) had its price target dropped by equities researchers at JPMorgan Chase & Co. from $48.00 to $46.00 in a report issued on Thursday, Benzinga reports. The brokerage currently has a "neutral" rating on the stock. JPMorgan Chase & Co.'s target price points to a potential upside of 14.45% from the stock's current price.

AMRZ has been the topic of a number of other reports. Weiss Ratings lowered shares of Amrize from a "hold (c-)" rating to a "sell (d+)" rating in a report on Thursday, October 8th. Barclays dropped their target price on Amrize from $55.00 to $40.00 and set an "equal weight" rating on the stock in a report on Monday, October 19th. Oppenheimer decreased their price target on Amrize from $55.00 to $52.00 and set an "outperform" rating for the company in a report on Monday, November 2nd. UBS Group lifted their price target on Amrize from $42.00 to $46.00 and gave the stock a "hold" rating in a report on Monday. Finally, Berenberg Bank downgraded Amrize from a "buy" rating to a "hold" rating and dropped their price objective for the company from $48.00 to $46.00 in a report on Monday, November 9th. Eight research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and five have given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $47.07.

Get Our Latest Analysis on AMRZ

Amrize Stock Down 0.5%

Shares of AMRZ traded down $0.22 during midday trading on Thursday, hitting $40.19. The company had a trading volume of 3,038,067 shares, compared to its average volume of 3,465,588. The company's 50-day simple moving average is $39.21 and its 200-day simple moving average is $49.79. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.67 and a current ratio of 1.07. The firm has a market capitalization of $22.23 billion, a P/E ratio of 18.18, a P/E/G ratio of 1.56 and a beta of 0.04. Amrize has a 1 year low of $35.78 and a 1 year high of $65.94.

Amrize (NYSE:AMRZ - Get Free Report) last released its earnings results on Wednesday, October 28th. The company reported $1.05 earnings per share for the quarter, hitting analysts' consensus estimates of $1.05. Amrize had a net margin of 9.93% and a return on equity of 10.02%. The firm had revenue of $3.77 billion for the quarter. During the same quarter in the previous year, the company posted $0.98 earnings per share. The firm's quarterly revenue was up 2.6% on a year-over-year basis. As a group, sell-side analysts expect that Amrize will post 2.30 EPS for the current year.

Insiders Place Their Bets

In related news, CEO Jan Jenisch acquired 4,000 shares of the firm's stock in a transaction on Wednesday, September 2nd. The stock was bought at an average price of $42.50 per share, for a total transaction of $170,000.00. Following the completion of the purchase, the chief executive officer directly owned 519,000 shares of the company's stock, valued at approximately $22,057,500. The trade was a 0.78% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Jacques Sanche acquired 4,150 shares of the company's stock in a transaction on Wednesday, August 26th. The shares were purchased at an average cost of $45.02 per share, for a total transaction of $186,833.00. Following the acquisition, the director owned 9,766 shares of the company's stock, valued at approximately $439,665.32. The trade was a 73.90% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Over the last three months, insiders purchased 34,155 shares of company stock valued at $1,461,276. 0.54% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. Pictet Asset Management Holding SA grew its position in shares of Amrize by 4.3% during the third quarter. Pictet Asset Management Holding SA now owns 6,126,150 shares of the company's stock worth $230,110,000 after acquiring an additional 253,512 shares during the last quarter. Renaissance Technologies LLC raised its position in Amrize by 10.4% in the 1st quarter. Renaissance Technologies LLC now owns 1,956,600 shares of the company's stock valued at $109,609,000 after purchasing an additional 183,900 shares during the last quarter. Amundi raised its position in Amrize by 30.9% in the 1st quarter. Amundi now owns 1,654,739 shares of the company's stock valued at $92,698,000 after purchasing an additional 390,750 shares during the last quarter. National Pension Service boosted its stake in Amrize by 7.5% during the 2nd quarter. National Pension Service now owns 1,493,022 shares of the company's stock worth $79,578,000 after purchasing an additional 103,962 shares during the period. Finally, Bank Julius Baer & Co. Ltd Zurich boosted its stake in Amrize by 8.8% during the 3rd quarter. Bank Julius Baer & Co. Ltd Zurich now owns 2,102,975 shares of the company's stock worth $78,985,000 after purchasing an additional 170,551 shares during the period.

Amrize Company Profile

(Get Free Report)

Amrize is a North American building materials and construction solutions company serving customers across the United States and Canada. Its operations span the construction materials and building envelope markets. The company supplies cement, aggregates, ready-mix concrete and asphalt, as well as roofing and other building-envelope products and services. These materials and solutions support residential, commercial and infrastructure projects. Amrize became an independent publicly traded company in 2025 through the spin-off of Holcim's North American business.

Further Reading

Analyst Recommendations for Amrize (NYSE:AMRZ)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amrize Right Now?

Before you consider Amrize, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amrize wasn't on the list.

While Amrize currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines